The fastest marathoner in the world Eliud Kipchoge, winner of three Olympic medals and first to run a marathon in under two hours, and three members of the NN Running Team will use Abbott’s Sport Libre Sense Glucose Biosensor, the world’s first glucose biosensor designed for athletes, during the NN Mission Marathon which will take place on April 18. In fact, Kipchoge and the NN Running Team are training with Abbott’s biosensor to monitor their glucose levels and develop customized training programs to achieve optimal athletic performance ahead of the Olympics.
The NN Mission Marathon is designed to be a fast paced race to give athletes the best chance to secure a qualification score for the rescheduled Olympic Games in Tokyo. The competition, in which over 75 athletes will participate, will take place at Enschede Twente Airport in the Netherlands.
Now for the first time, Abbott’s biosensor will allow Kipchoge to draw on molecular data in real time thanks to an app that constantly monitors glucose levels and allows you to design personalized nutritional plans both during training and during the race.
“We have used our revolutionary sensing technology to help world-class athletes like Eliud and everyday athletes live up to their optimum potential,” said Duncan Williams, division vice president, Biosensor Technology, Abbott. “Libre Sense will help make glucose monitoring common in athletic performance training and enable athletes to fuel their peak performance.”
Athletes will be able to wear the biosensor – the size of a 2 euro coin – on the back of the upper arm for up to 14 days. The biosensor will provide real-time blood glucose readings through the mobile app developed by Supersapiens, a sports technology company focused on improving athletic performance.